Skip to content

Prevention of Rebound Pain After Axillary Block

The Effect of Perineural Dexamethasone on Preventing Rebound Pain After Axillary Plexus Block in Hand Surgery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07313553
Enrollment
60
Registered
2026-01-02
Start date
2026-01-12
Completion date
2026-09-30
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative Care

Keywords

axillary nerve block, dexamethesone, rebound pain

Brief summary

This will be a single-center randomized double blind placebo control clinical trial. In the cohort of patients undergoing hand surgery under axillary nerve block, participants are recruited from those who are willing to consent and participate in the study, and will be randomly 1:1 divided into intervention group and placebo group.

Detailed description

After the arrival to the operation room, monitoring including pulse oximetry, electrocardiogram, and noninvasive blood pressure was applied. An 18 or 16-gauge IV cannula was inserted and Ringer's lactate infusion was started at a rate of 5 mL per kg per hour. Antibioprophylaxis was systematically administered with 2 grams ofCefazolin 30 minutes before induction. All patients were given an ultrasound-guided single-injection axillary plexus block by experienced anesthesiologists. Sedation with 2 mg midazolam intravenously before block was administered. In the group Dexamethasone (D), patients received axillary plexus block with a 30 ml of a 50/50 mixture of isobaric bupivacaine 0.5% and lidocaine 1%, containing 8 mg of dexamethasone. In the group control (X), patients received a 30 mlof a 50/50 mixture of isobaric bupivacaine 0.5% and lidocaine 1% containing 2 ml saline solution. For the axillary plexus block, patients were placed in a supine positionwith the arm in 90° of abduction and the forearm in flexion.A high frequency linear probe was placed on the transverse axis, over the axillary fold.The axillary artery, vein, and nerves surrounding the artery were visualized after scanning distally and proximally. The block needle (50 mm, 22G) was inserted in-plane from anterior to posterior, parallel to the ultrasound probe.It was advanced toward the musculocutaneous nerve (MCN) and local anesthetic was injected.Then, the needle was retracted and redirected deep relative to the axillary artery and local anesthetic was injectedaround the posterior aspect of the axillary artery and finallythe needle was retracted and redirected superficial to the axillary artery and local anesthetic was injected. Before the surgical incision, the effectiveness of the sensory blockade of the axillary plexus was evaluated by a cold test in the different territories. Post-operatively, all patients were put on systematic paracetamol 1 g every 6 hours, without exceeding 4 grams per day. when the postoperative pain score (NRS) was \>3/10, intravenous tramadol 100 mg was administered.

Interventions

OTHERSaline

2 ml saline solution are added to 30 ml of a 50/50 mixture of isobaric bupivacaine 0.5% and lidocaine 1%

Intervention group will receive 30 ml of a 50/50 mixture of isobaric bupivacaine 0.5% and lidocaine 1%, containing 8 mg of dexamethasone.

Sponsors

University Tunis El Manar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* • Age between 18 and 75 years old. * Patients are current for hand surgery under axillary plexus block. * Patients classified ASA physical status I, II and III

Exclusion criteria

* \- Contraindication to regional anesthesia. * Patient's disapproval. * Impaired cognition. * Patients whose surgery must be done under general anesthesia (complex hand surgery or association of other) * Allergy to paracetamol, dexamethasone or opioids

Design outcomes

Primary

MeasureTime frameDescription
incidence of Rebound pain1 hour postoperatively to 48 hours postoperativelyThe primary objective is the incidence of rebound pain, which was defined as severe pain (NRS ≥ 7) \[Numerical rate scale from 0 no pain to 10 worst pain\] at the surgical site during the first 48 hours postoperatively.

Secondary

MeasureTime frameDescription
Pain score at resthour 1, hour 48 postoperativePain score at rest using NRS \[Numerical Rate Scale from 0 no pain to 10 worst pain
Pain score at movementhour 1, hour 48 postoperativePain scores at mouvement using NRS \[Numerical Rate Scale from 0 no pain to 10 worst pain
The analgesic consumptionhour 1, hour 24 postoperativelyThe number of rescue analgesic dose during the first 24 hours
Duration of motor blockhour 1 postoperatively, 12 hours after nerve blockThe end of motor block was defined by a total flexion of fingers and arm.
Blood glucose levelafter nerve block, 24 hours after surgerylevel of glucose in serum blood

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026